Sharon_Ballesteros 2022

A spotlight on… Volition’s U.S. Clinical Product Strategy

August 18, 2022

Sharon was appointed as U.S. Head of Quality and Development Process in April 2022.

Bringing over 20 years of experience within the in vitro diagnostic industry to Volition, Sharon was excited to join the company at such a pivotal stage.

What has she been up to since joining Volition? Find out in the video below.

Volition 230619
Volition's U.S. Clinical Product Strategy with Sharon Belle

Stay in touch

To stay up to date with our developments, sign up to our email alerts, and follow Volition on LinkedInTwitterFacebook, or follow our dedicated Volition Veterinary LinkedIn account.